Envestnet Asset Management Inc Ironwood Pharmaceuticals Inc Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$5.58 - $8.61 $12,404 - $19,140	2,223 Added 13.3%	18,935 $123,000
Q1 2024 May 13, 2024	BUY	$8.32 - $15.45 $48,963 - $90,923	5,885 Added 54.35%	16,712 $145,000
Q4 2023 Feb 13, 2024	SELL	$8.79 - $11.51 $1,441 - $1,887	-164 Reduced 1.49%	10,827 $123,000
Q3 2023 Nov 13, 2023	SELL	$8.25 - $11.35 $1.93 Million - $2.66 Million	-233,928 Reduced 95.51%	10,991 $105,000
Q2 2023 Aug 04, 2023	SELL	$10.1 - $11.6 $2.64 Million - $3.03 Million	-261,035 Reduced 51.59%	244,919 $2.61 Million
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $2.92 Million - $3.54 Million	281,820 Added 125.74%	505,954 $5.32 Million
Q4 2022 Feb 07, 2023	BUY	$9.9 - $12.43 $96,802 - $121,540	9,778 Added 4.56%	224,134 $2.78 Million
Q3 2022 Nov 10, 2022	SELL	$10.14 - $12.38 $35,064 - $42,810	-3,458 Reduced 1.59%	214,356 $2.22 Million
Q2 2022 Aug 03, 2022	BUY	$11.05 - $12.72 $234,315 - $269,727	21,205 Added 10.79%	217,814 $2.51 Million
Q1 2022 May 04, 2022	BUY	$10.61 - $12.88 $452,049 - $548,765	42,606 Added 27.67%	196,609 $2.47 Million
Q4 2021 Feb 04, 2022	BUY	$10.86 - $13.95 $914,574 - $1.17 Million	84,215 Added 120.67%	154,003 $1.8 Million
Q3 2021 Oct 07, 2021	BUY	$11.92 - $13.92 $181,303 - $211,723	15,210 Added 27.87%	69,788 $911,000
Q2 2021 Aug 04, 2021	BUY	$10.16 - $13.11 $30,805 - $39,749	3,032 Added 5.88%	54,578 $702,000
Q1 2021 May 04, 2021	SELL	$9.04 - $11.86 $1,563 - $2,051	-173 Reduced 0.33%	51,546 $576,000
Q4 2020 Feb 02, 2021	BUY	$9.05 - $12.2 $98,581 - $132,894	10,893 Added 26.68%	51,719 $589,000
Q3 2020 Oct 09, 2020	SELL	$8.99 - $10.74 $511,081 - $610,569	-56,850 Reduced 58.2%	40,826 $367,000
Q2 2020 Jul 08, 2020	BUY	$9.14 - $11.97 $424,936 - $556,509	46,492 Added 90.83%	97,676 $1.01 Million
Q1 2020 Apr 23, 2020	SELL	$8.58 - $14.01 $284,890 - $465,188	-33,204 Reduced 39.35%	51,184 $516,000
Q4 2019 Feb 11, 2020	BUY	$8.22 - $14.0 $693,669 - $1.18 Million	84,388 New	84,388 $1.12 Million
Q1 2018 May 09, 2018	SELL	$11.13 - $13.63 $10,039 - $12,294	-902 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.07 - $14.87 $4,405 - $5,427	365 Added 67.97%	902 $14,000
Q2 2017 Aug 14, 2017	BUY	N/A	537	537 $10,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account